Key facts
- Active ingredient
- Ribavirin
- Drug class
- Nucleoside Analog Antiviral
- Form
- Tablet
- Strength
- Ribavirin 200MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Ribavirin 400MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Roche
- What the pharmacy pays
- ~$13.52 for 30 — not your price
- FDA application
- NDA021511
- Availability
- Discontinued (per FDA)
Drug class
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Copegus treat?
- Copegus (Ribavirin) may be used to treat human adenovirus infections, west nile fever, respiratory syncytial virus infections, chronic hepatitis c, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How much does Copegus cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $13.52 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Copegus?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Copegus. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Copegus?
- Copegus is marketed by Roche. You can see Roche's full profile, rating, and other products on pharmaranks.
- Is Copegus a brand-name or generic drug?
- Copegus is a brand-name product with the active ingredient Ribavirin. Lower-cost generic equivalents containing Ribavirin are available — ask your pharmacist.
- Is Copegus available over the counter?
- No. Copegus is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Copegus come in?
- Copegus is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Copegus?
- Copegus is classified as nucleoside analog antiviral, per the FDA's Established Pharmacologic Class.
- Is Copegus FDA-registered?
- Copegus is on record with the U.S. FDA under application number NDA021511. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about RIBAVIRIN
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 67,388 reports naming RIBAVIRIN — the active ingredient in Copegus, and the FDA flagged 59% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- fatigue10,158 reports
- anaemia8,754 reports
- nausea7,830 reports
- rash5,588 reports
- headache5,082 reports
- pruritus4,790 reports
- vomiting3,984 reports
- diarrhoea3,933 reports
Read these as a signal, not a rate. A report does not mean RIBAVIRIN caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Copegus head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
copegus
New